Becton Dickinson

By person

29 insiders · 22 transactions

14.8×

Thomas E. Polen holds 14.8 times base salary in stock. $20.76M of shares against $1.40M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas E. Polen last reported holding, valued at $188.49, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Polen Thomas E Jr

Chairman, CEO and President

—

$1.17M (2) scheduled

−$1.17M

110,163

0.0404%

$20.76M

+44.0%

Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

—

$784.16K (5) scheduled

−$784.16K

13,172

0.0048%

$2.48M

+52.1%

Goette Roland

EVP and President, EMEA

—

$440.89K (1)

−$440.89K

14,856

0.0055%

$2.80M

+17.4%

SCOTT BERTRAM L

Director

—

$212.35K (2)

−$212.35K

36,763

0.0135%

$6.93M

+0.4%

Feld Michael

EVP, Chief Revenue Officer

—

$167.36K (12) scheduled

−$167.36K

19,720

0.0072%

$3.72M

+70.2%

RING TIMOTHY M

Director

—

59,160

0.0217%

$11.15M

+3.5%

Muhsin Bilal

EVP & President Connected Care

—

41,359

0.0152%

$7.80M

+474.4%

Jones Christopher Ian Montague

Director

—

24,304

0.0089%

$4.58M

+9.1%

Neal Shana Carol

EVP and Chief People Officer

—

23,966

0.0088%

$4.52M

+19.3%

DelOrefice Christopher

EVP & Chief Financial Officer

—

22,982

0.0084%

$4.33M

+79.7%

Fraser Claire

Director

—

22,226

0.0082%

$4.19M

−3.7%

BURZIK CATHERINE M

Director

—

14,264

0.0052%

$2.69M

+7.0%

Menziuso Peter

EVP and President, BDI

—

14,258

0.0052%

$2.69M

—

Byrd Richard

EVP & President Interventional

—

13,849

0.0051%

$2.61M

+128.5%

Ezell Antoine C

EVP, President Americas & CMO

—

11,970

0.0044%

$2.26M

+28.4%

ECKERT R ANDREW

Director

—

10,423

0.0038%

$1.96M

+24.2%

Henderson Jeffrey William

Director

—

9,143

0.0034%

$1.72M

+62.8%

Shan David

EVP and Chief ISC Officer

—

8,926

0.0033%

$1.68M

+56.8%

Roque Vitor

EVP & Chief Financial Officer

—

8,041

0.0030%

$1.52M

+44.1%

Minnix Lanesha

EVP and General Counsel

—

7,492

0.0028%

$1.41M

—

HAYES GREGORY

Director

—

7,159

0.0026%

$1.35M

+47,627%

Quinn Michelle

EVP and General Counsel

—

6,927

0.0025%

$1.31M

+39.8%

Mocherla Pavan Kumar

EVP & President, Greater Asia

—

5,763

0.0021%

$1.09M

+218.0%

Byington Carrie L

Director

—

5,018

0.0018%

$945.84K

+67.8%

Brown William M

Director

—

4,663

0.0017%

$878.93K

+77.0%

Waldstreicher Joanne

Director

—

3,391

0.0012%

$639.17K

+148.8%

Spikner Pamela L.

SVP Controller & CAO

—

3,323

0.0012%

$626.35K

+167.6%

Huffines Robert Luther

Director

—

1,279

0.0005%

$241.08K

+127,800%

Wright Jacqueline

Director

—

1,279

0.0005%

$241.08K

+127,800%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Feld Michael

26 Aug 2026

EVP, Chief Revenue Officer

Sold on a plan

165

$188.49

$31.10K

Feld Michael

27 Jul 2026

EVP, Chief Revenue Officer

Sold on a plan

$157.13

$11.78K

Feld Michael

26 Jun 2026

EVP, Chief Revenue Officer

Sold on a plan

$152.80

$11.46K

Garrison Michael David

24 Jun 2026

EVP & Pres Med.Essntl&BioPharm

Sold on a plan

1,100

$145.66

$160.23K

Garrison Michael David

10 Jun 2026

EVP & Pres Med.Essntl&BioPharm

Sold on a plan

1,100

$151.48

$166.63K

Feld Michael

26 May 2026

EVP, Chief Revenue Officer

Sold on a plan

$147.35

$11.05K

Feld Michael

27 Apr 2026

EVP, Chief Revenue Officer

Sold on a plan

$151.94

$11.24K

Feld Michael

26 Mar 2026

EVP, Chief Revenue Officer

Sold on a plan

$156.83

$11.76K

Feld Michael

26 Feb 2026

EVP, Chief Revenue Officer

Sold on a plan

$181.84

$13.64K

Feld Michael

26 Jan 2026

EVP, CRO & Pres. Life Sciences

Sold on a plan

$202.73

$15.20K

Feld Michael

26 Dec 2025

EVP, CRO & Pres. Life Sciences

Sold on a plan

$196.08

$14.51K

Garrison Michael David

17 Dec 2025

EVP & Pres Med.Essntl&BioPharm

Sold on a plan

629

$196.03

$123.30K

Feld Michael

1 Dec 2025

EVP, CRO & Pres. Life Sciences

Sold on a plan

$193.36

$14.50K

Feld Michael

27 Oct 2025

EVP & President, Life Sciences

Sold on a plan

$186.01

$10.60K

Feld Michael

26 Sep 2025

EVP & President, Life Sciences

Sold on a plan

$181.03

$10.50K

Show all 22 transactions →

By person

Individual transactions

What was left out